13F-HR filed by HighVista Strategies LLC
HighVista Strategies LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 69 holding rows worth $125,607,000.
- Accession
- 0001172661-22-000519
- Filer
- CIK 1335325
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 69 entries on the cover page, a total value of $125,607,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $125,607,000 with VALUE read as thousands by filing date, 13F file number 028-14212. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DELL TECHNOLOGIES INC CL C | 24703L202 | Stock | 355,444 | $19,965,000 | thousands by filing date | |
| COUPANG INC | 22266T109 | CL A | 256,264 | $7,529,000 | thousands by filing date | |
| XILINX INC | 983919101 | COM | 24,173 | $5,125,000 | thousands by filing date | |
| MSD ACQUISITION CORP | G5709C117 | UNIT 03/25/2026 | 500,000 | $5,080,000 | thousands by filing date | |
| IHS MARKIT LTD | G47567105 | SHS | 32,743 | $4,352,000 | thousands by filing date | |
| COHERENT INC | 192479103 | COM | 13,600 | $3,625,000 | thousands by filing date | |
| NUANCE COMMUNICATIONS INC | 67020Y100 | COM | 64,841 | $3,587,000 | thousands by filing date | |
| PEOPLE'S UNITED FINANCIAL INC | 712704105 | COM | 196,100 | $3,495,000 | thousands by filing date | |
| CYRUSONE INC | 23283R100 | COM | 38,700 | $3,472,000 | thousands by filing date | |
| CHANGE HEALTHCARE INC | 15912K100 | COM | 162,100 | $3,466,000 | thousands by filing date | |
| CATALYST PARTNRS ACQUISITN C | G19550113 | UNIT 99/99/9999 | 200,000 | $2,002,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 21,433 | $1,992,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 62,906 | $1,965,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 5,562 | $1,948,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 53,840 | $1,712,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 101,144 | $1,691,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 54,103 | $1,679,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 112,160 | $1,631,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 35,232 | $1,606,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 34,487 | $1,606,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 89,963 | $1,591,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 52,982 | $1,505,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 13,843 | $1,483,000 | thousands by filing date | |
| GRITSTONE BIO INC | 39868T105 | COM | 113,752 | $1,463,000 | thousands by filing date | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 45,992 | $1,412,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 28,078 | $1,387,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 9,236 | $1,355,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 6,266 | $1,354,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 23,081 | $1,350,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 113,387 | $1,310,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 66,639 | $1,272,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 11,298 | $1,217,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 7,093 | $1,203,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 29,856 | $1,154,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 82,124 | $1,150,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 8,541 | $1,149,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 5,135 | $1,128,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 23,751 | $1,125,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 577,031 | $1,125,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 17,870 | $1,108,000 | thousands by filing date | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 13,538 | $1,079,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 30,999 | $1,060,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 44,294 | $1,053,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 11,039 | $1,031,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 46,913 | $1,024,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 31,493 | $1,014,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 40,549 | $979,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 56,901 | $974,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 29,753 | $973,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 40,619 | $960,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 39,777 | $919,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 43,497 | $917,000 | thousands by filing date | |
| DB COMMODITY INDEX TRACKING | 46138B103 | ETF | 42,396 | $881,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 54,012 | $867,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 38,347 | $839,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 46,264 | $820,000 | thousands by filing date | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 89,220 | $759,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 2,580 | $699,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 18,782 | $692,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 44,967 | $687,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 27,010 | $630,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 40,612 | $578,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 33,850 | $565,000 | thousands by filing date | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 18,796 | $544,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 50,942 | $477,000 | thousands by filing date | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 65,068 | $472,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 58,965 | $411,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 20,659 | $185,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 22,434 | $149,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-000519 | this filing | 2022-02-14 | acceptance time not in the bulk data set |